Beyond the Bandage: How Axiostat Supports Modern Bleeding Control
When bleeding is moderate to severe, a dressing needs to do more than simply cover the wound. Effective bleeding management requires rapid action and appropriate support at the site of injury. This is where a specialised hemostatic dressing can play an important role.
Axiostat is a hemostatic dressing designed to help control moderate to severe bleeding. It is made with 100% Chitosan and uses Protonated Bioadhesive Technology(PBT)Ⓡ to support interaction with blood components at the bleeding site. This interaction is an important part of how Axiostat supports the body’s natural hemostatic process.
Why Conventional Dressings May Not Be Enough
Conventional gauze is commonly used to absorb blood and apply physical pressure to a wound. While this can be useful in many situations, moderate to severe bleeding may require additional hemostatic support.
A hemostatic dressing is specifically designed to assist with bleeding control. Instead of functioning only as an absorbent layer, it is designed to interact with the bleeding site and support the natural processes involved in clot formation.
Axiostat provides this additional approach through its combination of 100% chitosan and Protonated Bioadhesive Technology(PBT)Ⓡ.
Protonated Bioadhesive Technology(PBT)Ⓡ: Supporting the Hemostatic Process
Protonated Bioadhesive Technology(PBT)Ⓡ is the technology behind Axiostat’s bioadhesive and hemostatic mechanism.
The technology is designed around the interaction between the positively charged dressing surface and blood components at the site of bleeding. This interaction supports platelet activity and processes involved in coagulation and clot formation.
It is important to distinguish the two:
- 100% Chitosan is the material used in Axiostat.
- Protonated Bioadhesive Technology(PBT)Ⓡ is the technology that supports its hemostatic mechanism.
- The positively charged chitosan surface interacts with negatively charged blood components.
- This interaction supports the body’s natural hemostatic response.
Together, these elements provide Axiostat with its purpose-designed approach to bleeding management.
From Blood Interaction to Clot Formation
The hemostatic mechanism involves multiple stages.
First, the positively charged surface of the dressing interacts with negatively charged blood components. This creates strong interaction at the bleeding site.
Next, the interaction supports platelet activation and aggregation. Platelets play an important role in the body’s response to vascular injury and contribute to the formation of an initial clot.The process also supports the coagulation pathway, including processes involved in fibrin formation. Fibrin helps create a more stable structure at the site of bleeding.
Axiostat’s technology describes these stages as charge-based adhesion, platelet activation, clotting cascade activation, and fibrin microthrombi or plug formation.
Designed for Different Bleeding Situations
Axiostat is available in different formats designed for specific bleeding-control applications. Its range includes rolled gauze, Z-fold gauze, patches, and vascular patches.
These formats can support use across emergency, trauma, and vascular settings, depending on the product and its intended application.
The choice of dressing and application method should always depend on the nature and severity of the bleeding and the applicable clinical protocol.
Why the Material Matters
The material used in a hemostatic dressing plays an important role in how it interacts with blood.
With 100% Chitosan, Axiostat is designed to create a positively charged surface that interacts with negatively charged blood components. This electrostatic interaction is central to its bioadhesive and hemostatic mechanism.
Rather than simply absorbing blood, the dressing is designed to actively interact at the site of bleeding and support processes involved in clot formation.
This distinction is particularly relevant when managing moderate to severe bleeding, where rapid and appropriate hemostatic support can be important.
Frequently Asked Questions
1. What is Axiostat?
Axiostat is a hemostatic dressing made with 100%
Chitosan and designed to help control moderate to severe bleeding. It uses Protonated Bioadhesive Technology(PBT)Ⓡ to support interaction with blood components at the bleeding site.
2. How does Axiostat interact with blood?
Its positively charged chitosan surface interacts with negatively charged blood components at the injury site. This interaction supports platelet activity, coagulation, and clot formation as part of the body’s natural hemostatic response.
3. What is Protonated Bioadhesive Technology(PBT)Ⓡ?
Protonated Bioadhesive Technology(PBT)Ⓡ is the technology used in Axiostat to support charge-based interaction with blood components. It is associated with processes including platelet activation, clotting cascade activation, and fibrin plug formation.
4. What makes Axiostat different from conventional gauze?
Conventional gauze primarily absorbs blood and provides physical pressure. Axiostat is specifically designed as a hemostatic dressing, using 100% Chitosan and Protonated Bioadhesive Technology(PBT)Ⓡ to support the body’s natural hemostatic process.
5. Can Axiostat replace professional medical treatment?
No. Axiostat is intended to provide hemostatic support while appropriate medical care is obtained. It does not replace professional medical evaluation, definitive treatment, or surgical care. It should be used according to its applicable Instructions for Use and clinical protocols.
Conclusion
When managing moderate to severe bleeding, the role of a dressing goes beyond simply covering the wound. Axiostat combines 100% Chitosan with Protonated Bioadhesive Technology(PBT)Ⓡ to support hemostasis through interaction with blood components at the bleeding site. Its positively charged chitosan surface interacts with negatively charged blood components, supporting platelet activity, coagulation, and clot formation.
As a purpose-designed hemostatic dressing, Axiostat provides an option for bleeding management in appropriate emergency, trauma, and vascular applications.
Disclaimer: For informational purposes only. Product availability, indications, and regulatory status may vary by country. Refer to locally approved labeling and instructions for use.
